Highlights • We found rVSVΔG-ZEBOV-GP to be immunogenic at 28- and 180-days post vaccination.• At 28 days post-vaccination, seroresponse rate was higher in the high-risk group.• There is a significant… Click to show full abstract
Highlights • We found rVSVΔG-ZEBOV-GP to be immunogenic at 28- and 180-days post vaccination.• At 28 days post-vaccination, seroresponse rate was higher in the high-risk group.• There is a significant pairwise correlation at 28 days post-vaccination between assays.• One dose of rVSVΔG-ZEBOV-GP induces a cellular response that increased with time.
               
Click one of the above tabs to view related content.